PMID- 37088446 OWN - NLM STAT- MEDLINE DCOM- 20230724 LR - 20231025 IS - 1097-6809 (Electronic) IS - 0741-5214 (Linking) VI - 78 IP - 2 DP - 2023 Aug TI - Poor utilization of palliative care among Medicare patients with chronic limb-threatening ischemia. PG - 464-472 LID - S0741-5214(23)00541-4 [pii] LID - 10.1016/j.jvs.2023.02.023 [doi] AB - OBJECTIVE: Patients with chronic limb-threatening ischemia (CLTI) experience high annual mortality and would benefit from timely palliative care intervention. We sought to better characterize use of palliative care among patients with CLTI in the Medicare population. METHODS: Using Medicare data from 2017 to 2018, we identified patients with CLTI, defined as two or more encounters with a CLTI diagnosis code. Palliative care evaluations were identified using ICD-10-CM Z51.5 "Encounter for palliative care." Time intervals between CLTI diagnosis, palliative consultation, and death or end of follow-up were calculated. Associations between patient demographics, comorbidities, and palliative care consultation were assessed. RESULTS: A total of 12,133 Medicare enrollees with complete data were categorized as having CLTI. Of these, 7.4% (894) underwent a palliative care evaluation at a median of 170 days (interquartile range, 45-352 days) from their CLTI diagnosis. Compared with those who did not undergo evaluation, palliative patients were more likely to be dual eligible for Medicaid (45.2% vs 38.1%; P < .001) and had more comorbid conditions (P < .001). After controlling for gender and race, age (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.02-1.04), dual eligibility (OR, 1.40; 95% CI, 1.22-1.62), solid organ malignancy (OR, 2.82; 95% CI, 1.92-4.14), hematologic malignancy (OR, 2.24; 95% CI, 1.27-3.98), congestive heart failure (OR, 1.44; 95% CI, 1.15-1.88), complicated diabetes (OR, 1.35; 95% CI, 1.11-1.65), dementia (OR, 1.32; 95% CI, 1.04-1.66), and severe renal failure (OR, 1.56; 85% CI. 1.24-1.98) were independently associated with palliative care evaluation. During mean follow up of 410 +/- 220 days, 16.9% (2044) of patients died at a mean of 268 (+/-189) days after their CLTI diagnosis. Among living patients, only 3.2% (325) underwent palliative evaluation. Comparatively, 27.8% (569) of patients who died received palliative care at a median of 196 days (interquartile range, 55-362 days) after their diagnosis and 15 days (interquartile range, 5-63 days) prior to death. CONCLUSIONS: Despite high mortality, palliative care services were rarely provided to Medicare patients with CLTI. Age, medical complexity, and income status may play a role in the decision to consult palliative care. When obtained, evaluations occurred closer to time of death than to time of CLTI diagnosis, suggesting misuse of palliative care as end-of-life care. CI - Copyright (c) 2023 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Kwong, Mimmie AU - Kwong M AD - Department of Surgery, Division of Vascular Surgery, University of California Davis School of Medicine, Sacremento, CA. Electronic address: mdkwong@ucdavis.edu. FAU - Rajasekar, Ganesh AU - Rajasekar G AD - Department of Public Health Sciences, University of California Davis School of Medicine, Sacremento, CA. FAU - Utter, Garth H AU - Utter GH AD - Department of Surgery, Division of Trauma, Acute Care Surgery, and Surgical Critical Care, University of California Davis School of Medicine, Sacremento, CA. FAU - Nuno, Miriam AU - Nuno M AD - Department of Public Health Sciences, University of California Davis School of Medicine, Sacremento, CA. FAU - Mell, Matthew W AU - Mell MW AD - Department of Surgery, Division of Vascular Surgery, University of California Davis School of Medicine, Sacremento, CA. LA - eng PT - Journal Article DEP - 20230422 PL - United States TA - J Vasc Surg JT - Journal of vascular surgery JID - 8407742 SB - IM CIN - J Vasc Surg. 2023 Aug;78(2):473-474. PMID: 37481277 MH - Humans MH - Aged MH - United States MH - Chronic Limb-Threatening Ischemia MH - Risk Factors MH - Palliative Care MH - *Peripheral Arterial Disease MH - *Endovascular Procedures/adverse effects MH - Treatment Outcome MH - Limb Salvage/adverse effects MH - Ischemia/diagnosis/therapy/etiology MH - Medicare MH - Retrospective Studies MH - Chronic Disease OTO - NOTNLM OT - Chronic limb threatening ischemia OT - Hospice OT - Medicare OT - Palliative Care OT - Peripheral arterial disease EDAT- 2023/04/24 00:41 MHDA- 2023/07/24 06:42 CRDT- 2023/04/23 19:36 PHST- 2022/11/15 00:00 [received] PHST- 2023/01/20 00:00 [revised] PHST- 2023/02/06 00:00 [accepted] PHST- 2023/07/24 06:42 [medline] PHST- 2023/04/24 00:41 [pubmed] PHST- 2023/04/23 19:36 [entrez] AID - S0741-5214(23)00541-4 [pii] AID - 10.1016/j.jvs.2023.02.023 [doi] PST - ppublish SO - J Vasc Surg. 2023 Aug;78(2):464-472. doi: 10.1016/j.jvs.2023.02.023. Epub 2023 Apr 22.